Compounds > simendan
Page last updated: 2024-08-24

simendan and Subarachnoid Hemorrhage

simendan has been researched along with Subarachnoid Hemorrhage in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (81.82)24.3611
2020's2 (18.18)2.80

Authors

AuthorsStudies
Ben Hassen, W; Caillard, A; Chousterman, BG; Labeyrie, MA; Mebazaa, A; Trinh-Duc, A1
Biais, M; Carrie, C; Cottenceau, V; Gariel, F; Petit, L; Poutier, B; Sauvage, N1
Andereggen, L; Kashefiolasl, S; Konczalla, J; Marbacher, S; Mrosek, J; Schubert, GA; Wanderer, S1
Gessler, F; Konczalla, J; Mrosek, J; Seifert, V; Wanderer, S1
Goraj, R; Jalali, R; Nosek, K; Onichimowski, D; Pawlos, A; Tuyakov, B; Wińska, A1
Brasseur, A; De Backer, D; Taccone, FS; Vincent, JL1
Makris, D; Papanikolaou, J; Tsolaki, V; Zakynthinos, E1
Eforakopoulou, M; Georgiadou, M; Katsioula, E; Pavlou, H; Sarafidou, P; Varvarousi, G; Xanthos, T1
Gueresir, E; Konczalla, J; Mrosek, J; Platz, J; Schuss, P; Seifert, V; Vatter, H; Wanderer, S1
Atalik, E; Avunduk, MC; Baysefer, A; Cengiz, SL; Erdi, MF; Mehmetoglu, I; Sönmez, FC; Tosun, M1
Busani, S; Cobelli, M; Girardis, M; Pasetto, A; Rinaldi, L; Severino, C1

Reviews

1 review(s) available for simendan and Subarachnoid Hemorrhage

ArticleYear
Role of levosimendan in the management of subarachnoid hemorrhage.
    The American journal of emergency medicine, 2016, Volume: 34, Issue:2

    Topics: Cardiotonic Agents; Humans; Hydrazones; Myocardial Stunning; Pyridazines; Simendan; Subarachnoid Hemorrhage

2016

Other Studies

10 other study(ies) available for simendan and Subarachnoid Hemorrhage

ArticleYear
Effects of levosimendan on occurrence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a case-control study.
    Critical care (London, England), 2021, 11-16, Volume: 25, Issue:1

    Topics: Case-Control Studies; Humans; Simendan; Subarachnoid Hemorrhage; Treatment Outcome; Vasospasm, Intracranial

2021
May levosimendan be safe and effective in refractory vasospasm despite adequate treatment with repeated angiography and milrinone infusion after subarachnoid haemorrhage?
    Anaesthesia, critical care & pain medicine, 2019, Volume: 38, Issue:6

    Topics: Aneurysm, Ruptured; Cardiotonic Agents; Cerebral Angiography; Cerebrospinal Fluid Leak; Computed Tomography Angiography; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Embolization, Therapeutic; Humans; Infusions, Intravenous; Intracranial Aneurysm; Intracranial Pressure; Magnesium Sulfate; Male; Middle Aged; Milrinone; Nimodipine; Simendan; Subarachnoid Hemorrhage; Vasospasm, Intracranial; Ventricular Dysfunction, Left

2019
Levosimendan as a therapeutic strategy to prevent neuroinflammation after aneurysmal subarachnoid hemorrhage?
    Journal of neurointerventional surgery, 2022, Volume: 14, Issue:4

    Topics: Animals; Basilar Artery; Humans; Neuroinflammatory Diseases; Rats; Rats, Sprague-Dawley; Simendan; Subarachnoid Hemorrhage; Vasospasm, Intracranial

2022
Levosimendan Reduces Prostaglandin F2a-dependent Vasoconstriction in Physiological Vessels and After Experimentally Induced Subarachnoid Hemorrhage.
    Current neurovascular research, 2018, Volume: 15, Issue:1

    Topics: Animals; Dinoprost; Dose-Response Relationship, Drug; Male; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Simendan; Subarachnoid Hemorrhage; Vasoconstriction; Vasodilator Agents

2018
Use of levosimendan in the treatment of cerebral vascular vasospasm: a case study.
    Drug design, development and therapy, 2018, Volume: 12

    Topics: Cerebral Angiography; Cerebral Arteries; Computed Tomography Angiography; Female; Humans; Hydrazones; Middle Aged; Pyridazines; Simendan; Subarachnoid Hemorrhage; Treatment Outcome; Vasoconstriction; Vasodilator Agents; Vasospasm, Intracranial

2018
Levosimendan for the treatment of subarachnoid hemorrhage-related cardiogenic shock.
    Intensive care medicine, 2013, Volume: 39, Issue:8

    Topics: Female; Humans; Hydrazones; Middle Aged; Pyridazines; Shock, Cardiogenic; Simendan; Subarachnoid Hemorrhage; Vasodilator Agents

2013
Early levosimendan administration may improve outcome in patients with subarachnoid hemorrhage complicated by acute heart failure.
    International journal of cardiology, 2014, Oct-20, Volume: 176, Issue:3

    Topics: Acute Disease; Adult; Cardiotonic Agents; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Hydrazones; Injections, Intravenous; Myocardial Contraction; Pyridazines; Simendan; Subarachnoid Hemorrhage; Time Factors

2014
Levosimendan, a new therapeutic approach to prevent delayed cerebral vasospasm after subarachnoid hemorrhage?
    Acta neurochirurgica, 2016, Volume: 158, Issue:11

    Topics: Animals; Hydrazones; Pyridazines; Rats; Simendan; Subarachnoid Hemorrhage; Vasospasm, Intracranial

2016
Beneficial effects of levosimendan on cerebral vasospasm induced by subarachnoid haemorrhage: an experimental study.
    Brain injury, 2010, Volume: 24, Issue:6

    Topics: Animals; Basilar Artery; Hydrazones; Infusions, Intravenous; Male; Pyridazines; Rabbits; Random Allocation; Simendan; Subarachnoid Hemorrhage; Vasodilator Agents; Vasospasm, Intracranial

2010
Levosimendan in cardiac failure after subarachnoid hemorrhage.
    The Journal of trauma, 2010, Volume: 68, Issue:5

    Topics: Acute Disease; Adult; Cardiotonic Agents; Critical Care; Embolization, Therapeutic; Female; Heart Failure; Humans; Hydrazones; Italy; Myocardial Stunning; Off-Label Use; Patient Selection; Pyridazines; Radiography; Simendan; Stroke Volume; Subarachnoid Hemorrhage; Treatment Outcome; Ventricular Function, Left

2010